Physiological relevance of LL-37 induced bladder inflammation and mast cells

Journal of Urology

Volumn 190, Issue 4 SUPPL, 2013, Pages 1596-1602

  Oottamasathien, Siam ^a,b   Jia, Wanjian ^a,b   Roundy, Lindsi McCoard ^a,b   Zhang, Jianxing ^b   Wang, Li ^a,b   Ye, Xiangyang ^b   Hill, A Cameron ^a,b   Savage, Justin ^a   Lee, Wong Yong ^a   Hannon, Ann Marie ^a,b   Milner, Sylvia ^a,b   Prestwich, Glenn D ^b,c  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^b Department of Surgery ^*  (United States)

^c Center for Therapeutic Biomaterials   (United States)

Author keywords

cystitis; interstitial inflammation; mast cells; meningomyelocele; urinary bladder

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; MYELOPEROXIDASE; TRYPTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHILD; CONTROLLED STUDY; CYSTITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL DYSRAPHISM; URINALYSIS;

EID: 84883811518     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.01.002     Document Type: Article

References (29)

1. S. Oottamasathien, W. Jia, and L. McCoard A murine model of inflammatory bladder disease: cathelicidin peptide induced bladder inflammation and treatment with sulfated polysaccharides J Urol 186 2011 1684
2. A. Nijnik, and R.E. Hancock The roles of cathelicidin LL-37 in immune defences and novel clinical applications Curr Opin Hematol 16 2009 41
3. M. Chromek, Z. Slamova, and P. Bergman The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection Nat Med 12 2006 636
4. J. Johansson, G.H. Gudmundsson, and M.E. Rottenberg Conformation- dependent antibacterial activity of the naturally occurring human peptide LL-37 J Biol Chem 273 1998 3718
5. R.A. Batler, S. Sengupta, and S.G. Forrestal Mast cell activation triggers a urothelial inflammatory response mediated by tumor necrosis factor-alpha J Urol 168 2002 819
6. D.J. Klumpp, and C.N. Rudick Summation model of pelvic pain in interstitial cystitis Nat Clin Pract Urol 5 2008 494
7. M.S. Larsen, S. Mortensen, and J. Nordling Quantifying mast cells in bladder pain syndrome by immunohistochemical analysis BJU Int 102 2008 204
8. X. Pang, G. Sant, and T.C. Theoharides Altered expression of bladder mast cell growth factor receptor (c-kit) in interstitial cystitis Urology 51 1998 939
9. R. Peeker, L. Enerback, and M. Fall Recruitment, distribution and phenotypes of mast cells in interstitial cystitis J Urol 163 2000 1009
10. C.N. Rudick, P.J. Bryce, and L.A. Guichelaar Mast cell-derived histamine mediates cystitis pain PLoS One 3 2008 e2096
11. G.R. Sant, D. Kempuraj, and J.E. Marchand The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis Urology 69 2007 34
12. C. Spanos, X. Pang, and K. Ligris Stress-induced bladder mast cell activation: implications for interstitial cystitis J Urol 157 1997 669
13. T.C. Theoharides, D. Kempuraj, and G.R. Sant Mast cell involvement in interstitial cystitis: a review of human and experimental evidence Urology 57 2001 47
14. S.J. Galli New concepts about the mast cell N Engl J Med 328 1993 257
15. S.J. Galli, S. Nakae, and M. Tsai Mast cells in the development of adaptive immune responses Nat Immunol 6 2005 135
16. P.S. Howard, D. Renfrow, and N.M. Schechter Mast cell chymase is a possible mediator of neurogenic bladder fibrosis Neurourol Urodyn 23 2004 374
17. F. Niyonsaba, K. Iwabuchi, and A. Someya A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis Immunology 106 2002 20
18. D.E. Bjorling, T.J. Jerde, and M.J. Zine Mast cells mediate the severity of experimental cystitis in mice J Urol 162 1999 231
19. R.R. Gonzalez, T. Fong, and N. Belmar Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis J Urol 173 2005 630
20. M.R. Saban, N.B. Nguyen, and T.G. Hammond Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation Am J Pathol 160 2002 2095
21. M.R. Saban, R. Saban, and T.G. Hammond LPS-sensory peptide communication in experimental cystitis Am J Physiol Renal Physiol 282 2002 F202
22. R. Saban, N.P. Gerard, and M.R. Saban Mast cells mediate substance P-induced bladder inflammation through an NK(1) receptor-independent mechanism Am J Physiol Renal Physiol 283 2002 F616
23. J. Zhang, X. Xu, and N.V. Rao Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea PLoS One 6 2011 e16658
24. D. Yang, O. Chertov, and J.J. Oppenheim Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37) J Leukocyte Biol 69 2001 691
25. O. Kutlu, E. Akkaya, and I.T. Koksal Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis Int Urol Nephrol 42 2010 393
26. J.H. Shie, H.T. Liu, and H.C. Kuo Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis/painful bladder syndrome Urology 79 2012 484 e7
27. T. Yamada, M. Nishimura, and H. Mita Increased number of apoptotic endothelial cells in bladder of interstitial cystitis patients World J Urol 25 2007 407
28. J. Kastrup, T. Hald, and S. Larsen Histamine content and mast cell count of detrusor muscle in patients with interstitial cystitis and other types of chronic cystitis Br J Urol 55 1983 495
29. B. Richter, A. Roslind, and U. Hesse YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis Histopathology 57 2010 371 Kidney Diseases